BMC Cancer
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free flaps: study protocol for a randomized phase II/III trial..
25:358.
2025
-
Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy.
24:984.
2024
-
A randomized control trial to compare mortality in recipients of leucoreduced and non-leucoreduced whole blood transfusion in patients with cancer in Uganda.
24:677.
2024
-
Physician-brief advice for promoting smoking cessation among cancer patients on treatment in low and middle-income countries: a scoping review.
24:149.
2024
-
Differences between physician and patient preferences for cancer treatments: a systematic review.
23:1126.
2023
-
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol.
23:379.
2023
-
Correction to: Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate.
22:182.
2022
-
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.
22:251.
2022
-
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer.
21:14.
2021
-
Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate.
21:1179.
2021
-
Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
21:957.
2021
-
Antagonists of the serotonin receptor 5A target human breast tumor initiating cells.
20:724.
2020
-
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
20:795.
2020
-
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting.
20:798.
2020
-
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
20:380.
2020
-
The relationship between physical activity and lymphoma: a systematic review and meta analysis.
20:962.
2020
-
Trajectories of physical activity, from young adulthood to older adulthood, and pancreatic cancer risk; a population-based case-control study in Ontario, Canada.
20:139.
2020
-
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
20:125.
2020
-
Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
19:884.
2019
-
Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review.
19:321.
2019
-
Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners.
19:130.
2019
-
Evaluation of an online knowledge translation intervention to promote cancer risk reduction behaviours: findings from a randomized controlled trial.
19:1138.
2019
-
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.
19:582.
2019
-
Predictors of mammographic density among women with a strong family history of breast cancer.
19:631.
2019
-
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
19:816.
2019
-
Teetering on a liver’s edge: a case report highlighting clinical decision-making in thrombocytopenia.
19:1058.
2019
-
Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
18:1031.
2018
-
Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
17:313.
2017
-
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.
16:555.
2016
-
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
15:882.
2015
-
Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
15:293.
2015
-
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.
14:871.
2014
-
Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review.
14:612.
2014
-
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’.
14:221.
2014
-
The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
14:415.
2014
-
A population-based study of rates of childbirth in recurrence-free female young adult survivors of Non-gynecologic malignancies.
13:30.
2013
-
Infections in pediatric acute promyelocytic leukemia: from the canadian infections in acute myeloid leukemia research group.
13:276.
2013
-
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer.
13:76-76.
2013
-
Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?.
12:314.
2012
-
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
12:523.
2012
-
Systematic review: conservative treatments for secondary lymphedema.
12:6.
2012
-
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.
11:291.
2011
-
Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
11:56.
2011
-
Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer.
10:41.
2010
-
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials.
10:675.
2010
-
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis.
9:34.
2009
-
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
9:272.
2009
-
The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors.
9:356.
2009
-
Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.
8:43.
2008
-
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
6:263.
2006
-
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
6:213.
2006
-
Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.
6:112.
2006
-
The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study.
6:39.
2006
-
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
6:34.
2006
-
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
5:17.
2005
-
Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline.
4:71.
2004
-
An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: The witness project of Buffalo.
3:18.
2003
-
Circulating soluble Fas levels and risk of ovarian cancer.
3:33.
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)